Britannia Enters into Definitive Agreement with Rise Life Science to "Go Public" via Reverse Takeover of Rise Life Science
Toronto, Ontario--(Newsfile Corp. - May 3, 2021) - Britannia Bud Canada Holdings Inc. (d/b/a Britannia Life Sciences) ("Britannia") and RISE Life Science Corp. (CSE: RLSC) ("RISE") are pleased to announce that Britannia, RISE and 2830026 Ontario Inc. ("RISE Subco"), a wholly-owned subsidiary of RISE, have entered into a business combination agreement dated April 30, 2021 (the "Definitive Agreement") in respect of their previously-announced transaction. Completion of this transaction will...
2021-05-03 8:47 AM EDT
RISE Life Science Corp. Announces Closing of Non-Brokered Financing
Toronto, Ontario--(Newsfile Corp. - April 15, 2021) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announces that it has closed the final tranche of its previously announced non-brokered private placement offering of subscription receipts for gross proceeds of USD$621,000 through this issuance of 621 subscription receipts (the "Subscription Receipts") at a price of USD$1,000 per Subscription Receipt (the "Offering"). The gross proceeds of the Offering (the "Escrowed...
2021-04-15 5:31 PM EDT
RISE Life Science Corp. Announces Closing of Non-Brokered Financing
Toronto, Ontario--(Newsfile Corp. - March 5, 2021) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announces that it has closed a non-brokered private placement offering of gross proceeds of subscription receipts for gross proceeds of USD$710,000 through this issuance of 710 subscription receipts (the "Subscription Receipts") at a price of USD$1,000 per Subscription Receipt (the "Offering"). The gross proceeds of the Offering (the "Escrowed Proceeds") are being held in escrow...
2021-03-05 8:00 AM EST
RISE Life Science Corp. Announces Proposed Transaction with Britannia Life Sciences
Toronto, Ontario--(Newsfile Corp. - January 22, 2021) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announces that it has entered into an agreement with Britannia Bud Canada Holdings Inc., dba Britannia Life Sciences ("Britannia"), dated January 21, 2021 to amend and confirm a letter of intent previously agreed to by the parties (the "Agreement"), pursuant to which RISE and Britannia have agreed to complete a business combination transaction (the "Proposed Transaction"). If...
2021-01-22 10:50 AM EST
RISE Life Science Advises Extension for Filing First Quarter Statements
Toronto, Ontario--(Newsfile Corp. - April 27, 2020) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or "Company") announces that it will not be in a position to file its interim financial statements for the fiscal quarter ended February 29, 2020 and the related management's discussion and analysis, as required by Part 4 and Part 5 of National Instrument 51-102: Continuous Disclosure Obligations (collectively, the "Q1 Filings") by the filing deadline of April 29, 2020.This news release is being...
2020-04-27 9:00 PM EDT
RISE Life Science Corp. Announces Revised Private Placement Structure Led by Canaccord Genuity Corp.
Toronto, Ontario--(Newsfile Corp. - April 21, 2020) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announced on April 13, 2020 that it has entered into a binding letter agreement (the "Agreement") dated April 13, 2020 with HydRx Farms Ltd. o/a Scientus Pharma ("Scientus") to complete a business combination of RISE and Scientus (the "Transaction"). If completed, the Transaction will constitute a "fundamental change" of RISE pursuant to the policies of the Canadian Securities...
2020-04-21 1:00 PM EDT
RISE Life Science Corp. Announces Proposed Transaction with Scientus Pharma
Toronto, Ontario--(Newsfile Corp. - April 13, 2020) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announces that it has entered into a binding letter agreement (the "Agreement") dated April 13, 2020 with HydRx Farms Ltd. o/a Scientus Pharma ("Scientus") to complete a business combination of RISE and Scientus (the "Transaction"). If completed, the Transaction will constitute a "fundamental change" of RISE pursuant to the policies of the Canadian Securities Exchange (the...
2020-04-13 9:00 PM EDT
RISE Life Science Advises Extension for Filing Annual Statements
Toronto, Ontario--(Newsfile Corp. - April 1, 2020) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or "Company") announces that it will not be in a position to file its audited annual financial statements for the fiscal year ended November 30, 2019 and the related management's discussion and analysis, as required by Part 4 and Part 5 of National Instrument 51-102: Continuous Disclosure Obligations (collectively, the "Annual Filings") by the filing deadline of March 30, 2020.This news release is...
2020-04-01 8:35 AM EDT
RISE Life Science Announces Change of Auditor
Toronto, Ontario--(Newsfile Corp. - February 14, 2020) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or "Company") announces that it has changed its auditors from MNP LLP ("Former Auditor") to Baker Tilly WM LLP ("Successor Auditor"). At the request of the Company, the Former Auditor resigned as the auditor of the Company effective February 12, 2020 and the board of directors of the Company appointed the Successor Auditor as the Company's auditor effective February 13, 2020, until the...
2020-02-14 5:00 PM EST
RISE Life Science Announces Resignation of Director
Toronto, Ontario--(Newsfile Corp. - December 24, 2019) - RISE Life Science Corp. (CSE: RLSC) ("RISE") announced today that Michael Campbell has stepped down as a director of the Company effective December 24, 2019. RISE thanked Mr. Campbell for his service to the Board of Directors.The Canadian Securities Exchange has not reviewed this news release and does not accept responsibility for the adequacy or accuracy of this news release.For Investor inquiries, please contact:Scott Secord,...
2019-12-24 5:00 PM EST
RISE Life Science Provides Operational Update
Toronto, Ontario--(Newsfile Corp. - December 6, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company" or "RISE"), a company developing hemp-based products for the emerging CBD consumer category, today announces that it will discontinue its physical retail operations in California, and will focus its efforts on distribution partnerships and online sales of its 'nano' hemp-extract oral sprays, quick-dissolve oral tablets and topical balms and lotions products.Scott Secord, Executive...
2019-12-06 7:00 AM EST
RISE Life Science Announces Resignation of Director
Toronto, Ontario--(Newsfile Corp. - August 19, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE") announced today that Ryan Rocca has stepped down as a director of the Company effective August 16, 2019. RISE thanked Mr. Rocca for his service to the Board of Directors and wished him the best in his future endeavours.About RISE Life Science Corp.RISE is currently developing and evolving medical and adult-use hemp-based formulations to create general use health and...
2019-08-19 9:23 AM EDT
RISE Life Science Further Extends Escrow Release Date
Toronto, Ontario--(Newsfile Corp. - July 16, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE") announced today that it has further extended the date when proceeds of its April 1, 2019 financing may be released.On April 1, 2019, the Company announced that it had completed a third tranche of its previously announced offering (the "Offering") of unsecured convertible notes (the "Notes") and common share purchase warrants ("Warrants") of the Company. Proceeds of the third...
2019-07-16 8:00 AM EDT
RISE Life Science Extends Escrow Release Date
Toronto, Ontario--(Newsfile Corp. - June 30, 2019) - RISE Life Science Corp. (CSE: RLSC) (OTC: MCUIF) (the "Company and/or "RISE") announced today that it has extended the date when proceeds of its April 1, 2019 financing may be released.On April 1, 2019, the Company announced that it had completed a third tranche of its previously announced offering (the "Offering") of unsecured convertible notes (the "Notes") and common share purchase warrants ("Warrants") of the Company. Proceeds of the...
2019-06-30 8:00 AM EDT
RISE Life Science Launches Retail Location on Main Street in Santa Monica, California
Toronto, Ontario--(Newsfile Corp. - June 14, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") is pleased to announce that it has launched its first Life Bloom Organics retail location in Santa Monica, California.The Santa Monica store sells the entire Life Bloom OrganicsTM brand hemp-based CBD product line and other branded lifestyle accessories. It will also carry RISE's KarezzaTM brand hemp-based CBD sexual wellness product line. The Company anticipates that the...
2019-06-14 8:00 AM EDT
RISE Provides Operational Update
Toronto, Ontario--(Newsfile Corp. - April 30, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company" or "RISE") today provided a corporate update."The last 12 months marked a series of important accomplishments that we believe will set the stage for growth in 2019 and beyond," commented Scott Secord, Executive Chairman of RISE. "We are proud and excited about our growing line of high quality organic, non-GMO hemp-based CBD products with proprietary nanotized technology, designed to...
2019-04-30 8:00 AM EDT
RISE'S Hemp-Based CBD Product Now Approved for Distribution in Mexico
Toronto, Ontario--(Newsfile Corp. - April 17, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company" or "RISE") is pleased to announce that COFEPRIS, the Mexican Secretariat of Health's agency responsible for the regulation of a variety of food and health related products, has approved our Life Bloom Organics brand CBD Wellness Formulation for distribution in Mexico.RISE has also submitted its popular California Sleep Formulation to COFEPRIS for regulatory approval in Mexico - a market...
2019-04-17 10:05 AM EDT
RISE's Product Portfolio Grows with Intimacy Oral Spray,Topical Muscle Recovery Products and Oral-Dose Tablets
Toronto, Ontario--(Newsfile Corp. - April 16, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company" or "RISE") today announces the further expansion of its product portfolio with new offerings from its Life Bloom Organics brand.On March 20, 2019, the Company previously announced two new oral spray formulas to its suite of product offerings. To meet the specific needs of athletes, RISE launched a targeted Muscle Recovery Formula to enhance the daily routines of those with active...
2019-04-16 1:35 PM EDT
RISE Closes Third Tranche of Convertible Note Financing
Toronto, Ontario--(Newsfile Corp. - April 1, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company" or "RISE") is pleased to announce that it has completed a third tranche of its offering previously announced on November 14, 2018 (the "Offering") of unsecured convertible notes (the "Notes"), raising an additional C$2,349,000. Pursuant to the Offering, the Company has now raised an aggregate of C$7,874,000.The Notes will accrue interest at a rate of 12% per year, paid quarterly in cash to...
2019-04-01 10:00 PM EDT
RISE Announces Hemp-based CBD Products for Sports Recovery and PMS
Toronto, Ontario--(Newsfile Corp. - March 20, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE") expands its product portfolio with new offerings from its Life Bloom Organics brand launching in calendar Q1 2019 with even more products planned to roll out in Q2 2019. In response to the Company's growth and U.S. customer demands, Life Bloom Organics is adding two new oral spray formulas to its suite of product offerings. Athletes are a core client base of...
2019-03-20 8:00 AM EDT